371 related articles for article (PubMed ID: 16147975)
1. A novel glyco-conjugate vaccine against fungal pathogens.
Torosantucci A; Bromuro C; Chiani P; De Bernardis F; Berti F; Galli C; Norelli F; Bellucci C; Polonelli L; Costantino P; Rappuoli R; Cassone A
J Exp Med; 2005 Sep; 202(5):597-606. PubMed ID: 16147975
[TBL] [Abstract][Full Text] [Related]
2. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.
Pietrella D; Rachini A; Torosantucci A; Chiani P; Brown AJ; Bistoni F; Costantino P; Mosci P; d'Enfert C; Rappuoli R; Cassone A; Vecchiarelli A
Vaccine; 2010 Feb; 28(7):1717-25. PubMed ID: 20038431
[TBL] [Abstract][Full Text] [Related]
3. Whole glucan particles as a vaccine against murine aspergillosis.
Clemons KV; Danielson ME; Michel KS; Liu M; Ottoson NC; Leonardo SM; Martinez M; Chen V; Antonysamy MA; Stevens DA
J Med Microbiol; 2014 Dec; 63(Pt 12):1750-1759. PubMed ID: 25288643
[TBL] [Abstract][Full Text] [Related]
4. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A
PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183
[TBL] [Abstract][Full Text] [Related]
5. Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.
Bromuro C; Romano M; Chiani P; Berti F; Tontini M; Proietti D; Mori E; Torosantucci A; Costantino P; Rappuoli R; Cassone A
Vaccine; 2010 Mar; 28(14):2615-23. PubMed ID: 20096763
[TBL] [Abstract][Full Text] [Related]
6. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
[TBL] [Abstract][Full Text] [Related]
7. 6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.
Liao G; Zhou Z; Liao J; Zu L; Wu Q; Guo Z
ACS Infect Dis; 2016 Feb; 2(2):123-31. PubMed ID: 27624963
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development.
Liao G; Zhou Z; Burgula S; Liao J; Yuan C; Wu Q; Guo Z
Bioconjug Chem; 2015 Mar; 26(3):466-76. PubMed ID: 25671314
[TBL] [Abstract][Full Text] [Related]
9. Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.
Li WJ; Long K; Dong HL; Gao XM
Clin Vaccine Immunol; 2013 Apr; 20(4):582-9. PubMed ID: 23408527
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide-containing conjugate vaccines for fungal diseases.
Casadevall A; Pirofski LA
Trends Mol Med; 2006 Jan; 12(1):6-9. PubMed ID: 16309965
[TBL] [Abstract][Full Text] [Related]
11. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
12. Novel mouse monoclonal antibodies specifically recognizing β-(1→3)-D-glucan antigen.
Matveev AL; Krylov VB; Khlusevich YA; Baykov IK; Yashunsky DV; Emelyanova LA; Tsvetkov YE; Karelin AA; Bardashova AV; Wong SSW; Aimanianda V; Latgé JP; Tikunova NV; Nifantiev NE
PLoS One; 2019; 14(4):e0215535. PubMed ID: 31022215
[TBL] [Abstract][Full Text] [Related]
13. Developing a vaccine against aspergillosis.
Stevens DA; Clemons KV; Liu M
Med Mycol; 2011 Apr; 49 Suppl 1():S170-6. PubMed ID: 20608783
[TBL] [Abstract][Full Text] [Related]
14. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with mannan protects mice against systemic aspergillosis.
Liu M; Machová E; Neščáková Z; Medovarská I; Clemons KV; Martinez M; Chen V; Bystrický S; Stevens DA
Med Mycol; 2012 Nov; 50(8):818-28. PubMed ID: 22587733
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan.
Lipinski T; Fitieh A; St Pierre J; Ostergaard HL; Bundle DR; Touret N
J Immunol; 2013 Apr; 190(8):4116-28. PubMed ID: 23514738
[TBL] [Abstract][Full Text] [Related]
17. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
18. Potential of anti-Candida antibodies in immunoprophylaxis.
Cabezas J; Albaina O; Montañez D; Sevilla MJ; Moragues MD; Pontón J
Immunotherapy; 2010 Mar; 2(2):171-83. PubMed ID: 20635926
[TBL] [Abstract][Full Text] [Related]
19. Anti-beta-glucan antibodies in healthy human subjects.
Chiani P; Bromuro C; Cassone A; Torosantucci A
Vaccine; 2009 Jan; 27(4):513-9. PubMed ID: 19041357
[TBL] [Abstract][Full Text] [Related]
20. Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.
Xin H; Cartmell J; Bailey JJ; Dziadek S; Bundle DR; Cutler JE
PLoS One; 2012; 7(4):e35106. PubMed ID: 22563378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
